Insider trading
Officers, directors, and 10% owners buying and selling their own company's stock, from SEC Form 4 filings. Newest first.
Showing the last 10 days.Sign up free for 90 days
| Type | Symbol | Insider | Shares | Price | Value | Traded | Filed |
|---|---|---|---|---|---|---|---|
| Sell | — | Ares Capital Management Ii Llc Investment Advisor | 484,652 | $20.0M | Oct 30, 2026 | Nov 4, 2026 | |
| Exercise | HCA | Marks Mike A EVP and CFO | 4,585 | $376K | Oct 30, 2026 | Nov 4, 2026 | |
| Tax | HCA | Marks Mike A EVP and CFO | 2,287 | $1.1M | Oct 30, 2026 | Nov 4, 2026 | |
| Other | HCA | Marks Mike A EVP and CFO | 1,042 | $489K | Nov 2, 2026 | Nov 4, 2026 | |
| Tax | HBAN | Hingst Marcy C SEVP and General Counsel | 22,905 | $361K | Oct 30, 2026 | Nov 3, 2026 | |
| Sell | RDWR | Malka Gabriel Chief Operating Officer | 16,461 | $563K | Nov 2, 2026 | Nov 3, 2026 | |
| Tax | LTRX | Awsare Saleel President & CEO, Director | 76,259 | $458K | Nov 1, 2026 | Nov 3, 2026 | |
| Exercise | HCA | Schlosser Michael J EVP and Chief Clinical Officer | 4,928 | $406K | Oct 29, 2026 | Nov 2, 2026 | |
| Tax | HCA | Schlosser Michael J EVP and Chief Clinical Officer | 2,455 | $1.2M | Oct 29, 2026 | Nov 2, 2026 | |
| Sell | BFST | Cummings George W. III Director | 18,373 | $583K | Oct 29, 2026 | Nov 2, 2026 | |
| Buy | — | Venrock Healthcare Capital Partners III, L.P. 10% owner | 25,004 | $645K | Oct 30, 2026 | Oct 30, 2026 | |
| Sell | HOMB | Allison John W II Director | 13,500 | $406K | Oct 29, 2026 | Oct 30, 2026 | |
| Sell | DCOM | Basswood Capital Management, L.L.C. Director, Director-by-Deputization | 12,926 | $549K | Oct 27, 2026 | Oct 29, 2026 | |
| Sell | DCOM | Basswood Capital Management, L.L.C. Director, Director-by-Deputization | 18,403 | $779K | Oct 29, 2026 | Oct 29, 2026 | |
| Sell | RDWR | Goldriech Rivkah Chief People Officer | 28,402 | $990K | Oct 28, 2026 | Oct 29, 2026 | |
| Sell | RDWR | Aviv David Meleh Chief Technology Officer | 7,500 | $272K | Oct 28, 2026 | Oct 29, 2026 | |
| Sell | RDWR | Aviv David Meleh Chief Technology Officer | 30,000 | $1.0M | Oct 27, 2026 | Oct 28, 2026 | |
| Sell | DCOM | Basswood Capital Management, L.L.C. Director, Director-by-Deputization | 31,146 | $1.3M | Oct 23, 2026 | Oct 27, 2026 | |
| Sell | DCOM | Basswood Capital Management, L.L.C. Director, Director-by-Deputization | 75,013 | $3.2M | Oct 26, 2026 | Oct 27, 2026 | |
| Buy | — | Venrock Healthcare Capital Partners III, L.P. 10% owner | 2,045,440 | $37.7M | Oct 27, 2026 | Oct 27, 2026 | |
| Buy | CTEV | Ares Management Llc 10% owner | 70,834 | $1.7M | Oct 26, 2026 | Oct 27, 2026 | |
| Buy | CTEV | Ares Management Llc 10% owner | 70,834 | $1.7M | Oct 26, 2026 | Oct 27, 2026 | |
| Exercise | NIC | Atwell Robert Bruce Director | 10,000 | $564K | Oct 23, 2026 | Oct 27, 2026 | |
| Tax | NIC | Atwell Robert Bruce Director | 6,444 | $1.1M | Oct 23, 2026 | Oct 27, 2026 | |
| Sell | NIC | Atwell Robert Bruce Director | 3,556 | $609K | Oct 23, 2026 | Oct 27, 2026 | |
| Sell | HCSG | Bundick Jason J EVP/Gen. Counsel/Corp. Secty. | 18,239 | $458K | Oct 26, 2026 | Oct 27, 2026 | |
| Sell | GWRE | Mullen John P President | 1,800 | $337K | Oct 26, 2026 | Oct 27, 2026 | |
| Tax | AYI | Holcom Karen J SVP & Chief Financial Officer | 6,291 | $2.0M | Oct 24, 2026 | Oct 27, 2026 | |
| Buy | THRM | Mascarenas Paul Anthony Director | 20,000 | $533K | Oct 23, 2026 | Oct 26, 2026 | |
| Exercise | BWB | Baack Jerry J. CEO, Director | 46,933 | $351K | Oct 23, 2026 | Oct 26, 2026 | |
| Sell | AUB | Linderman Matthew L. EVP | 7,746 | $310K | Oct 22, 2026 | Oct 26, 2026 | |
| Sell | CHKP | Kremer Nataly Chief Product Officer | 3,185 | $478K | Oct 22, 2026 | Oct 26, 2026 |